Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2017-08-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于变更会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about a change in accounting policy, specifically related to the adoption of a revised accounting standard issued by the Ministry of Finance. It details the date of change, reasons, and the impact on financial statements. The document includes opinions from the board of directors, independent directors, and the supervisory board approving the change. The document is relatively short (1400 characters) and does not contain actual financial statements or detailed financial data. It is not a full annual or interim report, nor is it an audit report or earnings release. It is a regulatory announcement about accounting policy change, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories and is a compliance disclosure.
2017-08-28 Chinese
2017年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as a 2017 semi-annual financial report (半年度财务报告) of 启迪古汉集团股份有限公司, dated August 29, 2017. It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and changes in equity. The document explicitly states it is a half-year report and includes comprehensive financial data and analysis for the period ending June 30, 2017. The length is substantial (15,000 characters), and it is not merely an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2017
2017-08-28 Chinese
独立董事对第八届董事会临时会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion statement from independent directors regarding specific board meeting proposals, including special opinions on related party transactions, use of raised funds for the half-year period ending June 30, 2017, and changes in accounting policies. It references regulatory guidelines and compliance but does not contain full financial statements or comprehensive financial performance data. The document is focused on board/management oversight and opinions on governance and financial matters rather than being a full report or announcement of voting results. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification letter, so those categories are excluded.
2017-08-28 Chinese
第八届监事会临时会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at a supervisory board meeting of 启迪古汉集团股份有限公司 on August 28, 2017. It includes approval of the 2017 semi-annual report, a special report on the use of raised funds, and a change in accounting policy. The document is short (987 characters) and primarily reports on the meeting decisions and approvals rather than containing the full semi-annual report or detailed financial data. It is an official announcement of meeting resolutions and approvals, not the report itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2017-08-28 Chinese
2017年半年度募集资金存放和使用情况的专项报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2017 半年度募集资金存放和使用情况的专项报告" which translates to "2017 Half-Year Special Report on the Deposit and Use of Raised Funds." It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange regarding the management and use of raised funds. The content details the amount of funds raised through a non-public stock issuance, the bank accounts where the funds are held, agreements signed for fund supervision, and the actual use of the funds during the half-year period ending June 30, 2017. It includes detailed financial figures and tables about the raised funds usage and compliance with regulations. The document is a comprehensive report on the use of capital raised during the half-year period, containing substantive financial data and analysis. This fits the definition of an Interim / Quarterly Report (IR) because it is a comprehensive financial report for a period shorter than a full fiscal year and contains actual financial statements and substantive financial data about the use of raised funds during the half-year period. It is not merely an announcement or certification but a detailed report. Therefore, the correct classification is IR with high confidence. H1 2017
2017-08-28 Chinese
第八届董事会临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a board resolution announcement from the company's eighth board meeting held on August 28, 2017. It reports the approval of the 2017 semi-annual report, a special report on the use of raised funds, and a change in accounting policy. The document itself does not contain the full semi-annual report or detailed financial data but refers to other disclosures made on the same day for the full reports. The document length is short (650 characters), and it serves as an announcement of board decisions rather than the report itself. Therefore, it fits best under Board/Management Information (MANG) as it announces board meeting resolutions and approvals.
2017-08-28 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.